These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8009188)

  • 21. Vitamin D metabolites and calcium metabolism in patients with nephrotic syndrome and normal renal function.
    Goldstein DA; Haldimann B; Sherman D; Norman AW; Massry SG
    J Clin Endocrinol Metab; 1981 Jan; 52(1):116-21. PubMed ID: 6969729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal function and tubular phosphate handling in long-term cyclosporine- and tacrolimus-based immunosuppression in kidney transplantation.
    Falkiewicz K; Kamińska D; Nahaczewska W; Boratyńska M; Owczarek H; Klinger M; Woźniak M; Patrzałek D; Szyber P
    Transplant Proc; 2006; 38(1):119-22. PubMed ID: 16504680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease.
    Levin A; Bakris GL; Molitch M; Smulders M; Tian J; Williams LA; Andress DL
    Kidney Int; 2007 Jan; 71(1):31-8. PubMed ID: 17091124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin D status: effects on parathyroid hormone and 1, 25-dihydroxyvitamin D in postmenopausal women.
    Need AG; Horowitz M; Morris HA; Nordin BC
    Am J Clin Nutr; 2000 Jun; 71(6):1577-81. PubMed ID: 10837301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin in chronic renal failure.
    Franck H; Keck E; Issa S; Krüskemper HL; von Lilienfeld-Toal H
    Exp Clin Endocrinol; 1988 May; 91(2):202-6. PubMed ID: 3409970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of 24,25(OH)2D3 on PTH levels and bone histology in dogs with chronic uremia.
    Olgaard K; Finco D; Schwartz J; Arbelaez M; Teitelbaum S; Avioli L; Klahr S; Slatopolsky E
    Kidney Int; 1984 Dec; 26(6):791-7. PubMed ID: 6335904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence of effect of 24,25-dihydroxycholecalciferol on serum immunoreactive PTH in patients with persistent hyperparathyroidism after renal transplantation.
    Friedlander MA; Horst RL; Hawker CD
    Clin Nephrol; 1984 Oct; 22(4):206-10. PubMed ID: 6391769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No trend toward a spontaneous improvement of hyperparathyroidism and high bone turnover in normocalcemic long-term renal transplant recipients.
    Dumoulin G; Hory B; Nguyen NU; Bresson C; Fournier V; Bouhaddi M; Chalopin JM; Saint-Hillier Y; Regnard J
    Am J Kidney Dis; 1997 May; 29(5):746-53. PubMed ID: 9159310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
    Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Earlier decrease of FGF-23 and less hypophosphatemia in preemptive kidney transplant recipients.
    Barros X; Torregrosa JV; Martínez de Osaba MJ; Casals G; Paschoalin R; Durán CE; Campistol JM
    Transplantation; 2012 Oct; 94(8):830-6. PubMed ID: 23018879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo regulation of chromogranin A messenger ribonucleic acid in the parathyroid by 1,25-dihydroxyvitamin D: studies in normal rats and in chronic renal insufficiency.
    Soliman E; Canaff L; Fox J; Hendy GN
    Endocrinology; 1997 Jun; 138(6):2596-600. PubMed ID: 9165053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adaptation of middle aged rats to long-term restriction of dietary vitamin D and calcium.
    Armbrecht HJ; Forte LR
    Arch Biochem Biophys; 1985 Nov; 242(2):464-9. PubMed ID: 3840668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential changes in divalent ion metabolism after renal transplantation.
    Cotorruelo JG; De Francisco AL; Canga E; Amado JA; Riancho JA; Sanz de Castro S; Zubimendi JA; Arias M; González Macias J
    Transplant Proc; 1990 Aug; 22(4):1414-5. PubMed ID: 2389343
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function.
    Moosgaard B; Vestergaard P; Heickendorff L; Mosekilde L
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):35-42. PubMed ID: 17201799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum phosphate levels modify the impact of parathyroid hormone levels on renal outcomes in kidney transplant recipients.
    Doi Y; Hamano T; Ichimaru N; Tomida K; Obi Y; Fujii N; Yamaguchi S; Oka T; Sakaguchi Y; Matsui I; Kaimori JY; Abe T; Imamura R; Takahara S; Tsubakihara Y; Nonomura N; Isaka Y
    Sci Rep; 2020 Aug; 10(1):13766. PubMed ID: 32792668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin K status in relation to bone metabolism in patients with renal failure.
    Małyszko J; Wołczyński S; Skrzydlewska E; Małyszko JS; Myśliwiec M
    Am J Nephrol; 2002; 22(5-6):504-8. PubMed ID: 12381951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are low plasma levels of 25-(OH)vitamin D a major risk factor for hyperparathyroidism independent of calcitriol in renal transplant patients?
    Lomonte C; Antonelli M; Vernaglione L; Cazzato F; Casucci F; Chimienti D; Bruno A; Cocola S; Verrelli EA; Basile C
    J Nephrol; 2005; 18(1):96-101. PubMed ID: 15772930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of metabolic acidosis on serum 1,25(OH)2D3 levels in chronic renal failure.
    Lu KC; Lin SH; Yu FC; Chyr SH; Shieh SD
    Miner Electrolyte Metab; 1995; 21(6):398-402. PubMed ID: 8592483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephron Clin Pract; 2008; 110(1):c58-65. PubMed ID: 18724068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin D deficiency, parathyroid hormone levels, and bone disease among patients with end-stage liver disease and normal serum creatinine awaiting liver transplantation.
    Corey RL; Whitaker MD; Crowell MD; Keddis MT; Aqel B; Balan V; Byrne T; Carey E; Douglas DD; Harrison ME; Vargas HE; Rakela J
    Clin Transplant; 2014 May; 28(5):579-84. PubMed ID: 24628047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.